Difluprednate information

Difluprednate
Clinical data
Trade names	Durezol
AHFS/Drugs.com	Monograph
MedlinePlus	a609025
License data	US FDA: Difluprednate;
Routes of; administration	Eye drops
ATC code	D07AC19 (WHO) S01BA16 (WHO);
Legal status
Legal status	US: ℞-only;
Identifiers
	IUPAC name [(6S,8S,9R,10S,11S,13S,14S,17R)-17-(2-acetyloxyacetyl)-6,9-difluoro-11-hydroxy-10,13-dimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] butanoate;
CAS Number	23674-86-4 ;
PubChem CID	32037;
DrugBank	DB06781 ;
ChemSpider	391990 ;
UNII	S8A06QG2QE;
KEGG	D01266 ;
ChEBI	CHEBI:31485;
ChEMBL	ChEMBL1201749 ;
CompTox Dashboard (EPA)	DTXSID0046773 ;
ECHA InfoCard	100.041.636
Chemical and physical data
Formula	C27H34F2O7
Molar mass	508.559 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES [H][C@@]12CC[C@](OC(=O)CCC)(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C;
	InChI InChI=1S/C27H34F2O7/c1-5-6-23(34)36-26(22(33)14-35-15(2)30)10-8-17-18-12-20(28)19-11-16(31)7-9-24(19,3)27(18,29)21(32)13-25(17,26)4/h7,9,11,17-18,20-21,32H,5-6,8,10,12-14H2,1-4H3/t17-,18-,20-,21-,24-,25-,26-,27-/m0/s1; Key:WYQPLTPSGFELIB-JTQPXKBDSA-N;
	(what is this?) (verify)

Difluprednate, sold under the brand name Durezol, is a corticosteroid used for the treatment of post-operative ocular inflammation and pain.^[1]

It was approved for medical use in the United States in June 2008.^[1]^[2]^[3] It is available as a generic medication.^[4]

^ ^a ^b ^c "Durezol emulsion". DailyMed. 11 July 2022. Retrieved 7 March 2023.
^ "Drug Approval Package: Durezol (Difluprednate) NDA #022212". U.S. Food and Drug Administration (FDA). 25 July 2008. Retrieved 7 March 2023.
^ "Sirion Therapeutics Announces FDA Approval of Durezol for Treatment of Postoperative Ocular Inflammation and Pain" (Press release). Sirion Therapeutics, Inc. 2008-06-24. Retrieved 2008-06-30.
^ "Competitive Generic Therapy Approvals". U.S. Food and Drug Administration (FDA). 29 June 2023. Archived from the original on 29 June 2023. Retrieved 29 June 2023.

[Durezol_FDA_label-1] "Durezol emulsion". DailyMed. 11 July 2022. Retrieved 7 March 2023.

[2] "Drug Approval Package: Durezol (Difluprednate) NDA #022212". U.S. Food and Drug Administration (FDA). 25 July 2008. Retrieved 7 March 2023.

[3] "Sirion Therapeutics Announces FDA Approval of Durezol for Treatment of Postoperative Ocular Inflammation and Pain" (Press release). Sirion Therapeutics, Inc. 2008-06-24. Retrieved 2008-06-30.

[4] "Competitive Generic Therapy Approvals". U.S. Food and Drug Administration (FDA). 29 June 2023. Archived from the original on 29 June 2023. Retrieved 29 June 2023.

Difluprednate information

and 29 Related for: Difluprednate information

Difluprednate

Triamcinolone

Clobetasol

Corticosteroid

Glucocorticoid

Fluticasone propionate

Clobetasol propionate

Dexamethasone

Triamcinolone acetonide

Hydrocortisone

Fluticasone

Prednisone

Methylprednisolone

Cortisol

Topical steroid

Mometasone

Ketoconazole

Steroid

Betamethasone dipropionate

Fluocinolone acetonide

Progesterone

C27H34F2O7

Fluocinonide

Betamethasone

Fludrocortisone

Betamethasone valerate

Deflazacort

Prednisolone acetate

Methylprednisolone acetate